BioSpace News Archive

BioMidwest

Dr. James Lynch of Spine Nevada Becomes First Surgeon to Use Augmedics xvision Spine System with Recently FDA Cleared Perc Pin

Dr. James Lynch of Spine Nevada, a board-certified neurological surgeon with multiple fellowships in the field of spine, recently became the first surgeon to use the Augmedics xvision Spine System with Perc Pin.

September 23, 2021
·
3 min read
ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

ADC Therapeutics SA announced today that Chris Martin, Chief Executive Officer, will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference on Thursday, September 30th at 9:20 a.m. ET.

September 23, 2021
·
2 min read
KemPharm to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

KemPharm, Inc. today announced that Travis C. Mickle, Ph.D., President and Chief Executive Officer of KemPharm, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference taking place September 27-30, 2021.

September 23, 2021
·
2 min read
Biotech Bay

Nagoya City University Hospital is First in Japan to Treat Cancer Patients Using the Accuray Radixact® System with ClearRT™ Helical Fan-Beam kVCT Imaging

Accuray Incorporated (NASDAQ: ARAY) announced today that the Nagoya City University Hospital in Aichi has treated the first cancer patient in Japan using the Radixact ® System with ClearRT

September 23, 2021
·
6 min read
Drug Development

Appili Therapeutics Announces Last Patient Enrolled in Phase 3 Trial of Oral Avigan®/Reeqonus™ for the Treatment of Mild-to-Moderate COVID-19

Appili Therapeutics Inc. today announced it has completed enrollment in its global Phase 3 PRESECO (PREventing SEvere COVID-19) trial evaluating oral Avigan®/Reeqonus™ (favipiravir) as a potential COVID-19 treatment.

September 23, 2021
·
8 min read
Pharm Country

electroCore to Participate at Upcoming Investor Conferences - Sep 23, 2021

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced that its management team will give a corporate presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference.

September 23, 2021
·
1 min read
Drug Development

TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder

TFF Pharmaceuticals, Inc. today announced topline results from the recently completed Phase 1 clinical trial for Tacrolimus Inhalation Powder showing a promising safety profile and demonstrating therapeutic drug levels can be achieved at low doses.

September 23, 2021
·
10 min read
Drug Development

Daré Bioscience Initiates Phase 1/2 Clinical Study of DARE-VVA1, Intravaginal Tamoxifen for the Treatment of Vulvar and Vaginal Atrophy

Daré Bioscience, Inc. today announced the initiation of a Phase 1/2 clinical study of DARE-VVA1, a novel intravaginal tamoxifen product being developed for the treatment of moderate to severe vulvar and vaginal atrophy (VVA).

September 23, 2021
·
12 min read
Pharm Country

Celldex Announces Upcoming Presentation of CDX-0159 Phase 1b Results in Inducible Urticaria at the 2021 European Academy of Dermatology and Venereology (EADV) 30th Congress

Celldex Therapeutics, Inc. today announced that an abstract describing symptom control and quality of life measurements from the Phase 1b study of CDX-0159 in patients with antihistamine refractory cold contact urticaria (ColdU)

September 23, 2021
·
4 min read
Biotech Beach

Boundless Bio to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

Boundless Bio today announced that Chief Executive Officer, Zachary Hornby, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021, from 1:20-1:50 p.m. ET.

September 23, 2021
·
1 min read